372 related articles for article (PubMed ID: 29139091)
1. Pharmacological Approach to the Management of Crohn's Disease Patients with Perianal Disease.
Bermejo F; Guerra I; Algaba A; López-Sanromán A
Drugs; 2018 Jan; 78(1):1-18. PubMed ID: 29139091
[TBL] [Abstract][Full Text] [Related]
2. Management of perianal Crohn's disease.
Rutgeerts P
Can J Gastroenterol; 2000 Sep; 14 Suppl C():7C-12C. PubMed ID: 11023554
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of infliximab combined with surgical treatment of fistulizing perianal Crohn's disease: Comparative analysis according to fistula subtypes.
Park EJ; Song KH; Baik SH; Park JJ; Kang J; Lee KY; Goo JI; Kim NK
Asian J Surg; 2018 Sep; 41(5):438-447. PubMed ID: 28851611
[TBL] [Abstract][Full Text] [Related]
4. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL
J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
[TBL] [Abstract][Full Text] [Related]
5. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
Tonelli F; Giudici F; Asteria CR
Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
[TBL] [Abstract][Full Text] [Related]
8. Treatment of perianal Crohn's disease.
Zalieckas JM
Semin Pediatr Surg; 2017 Dec; 26(6):391-397. PubMed ID: 29126509
[TBL] [Abstract][Full Text] [Related]
9. Course and treatment of perianal disease in children newly diagnosed with Crohn's disease.
Keljo DJ; Markowitz J; Langton C; Lerer T; Bousvaros A; Carvalho R; Crandall W; Evans J; Griffiths A; Kay M; Kugathasan S; LeLeiko N; Mack D; Mamula P; Moyer MS; Oliva-Hemker M; Otley A; Pfefferkorn M; Rosh J; Hyams JS
Inflamm Bowel Dis; 2009 Mar; 15(3):383-7. PubMed ID: 19023863
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy.
Lahat A; Assulin Y; Beer-Gabel M; Chowers Y
J Crohns Colitis; 2012 Apr; 6(3):311-6. PubMed ID: 22405167
[TBL] [Abstract][Full Text] [Related]
11. Perianal Crohn's disease: a review.
Juncadella AC; Alame AM; Sands LR; Deshpande AR
Postgrad Med; 2015 Apr; 127(3):266-72. PubMed ID: 25746229
[TBL] [Abstract][Full Text] [Related]
12. Medical options for treating perianal Crohn's disease.
Griggs L; Schwartz DA
Dig Liver Dis; 2007 Oct; 39(10):979-87. PubMed ID: 17719859
[TBL] [Abstract][Full Text] [Related]
13. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG
Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797
[TBL] [Abstract][Full Text] [Related]
14. Approach to medical therapy in perianal Crohn's disease.
Vasudevan A; Bruining DH; Loftus EV; Faubion W; Ehman EC; Raffals L
World J Gastroenterol; 2021 Jul; 27(25):3693-3704. PubMed ID: 34321838
[TBL] [Abstract][Full Text] [Related]
15. Onset of severe perianal disease in Crohn's disease under treatment with infliximab: successful treatment with adalimumab and setons drainage.
Tursi A; Papa A; Maiorano M
Inflamm Bowel Dis; 2011 Feb; 17(2):676-8. PubMed ID: 20848475
[No Abstract] [Full Text] [Related]
16. Local injection of Infliximab for the treatment of perianal Crohn's disease.
Poggioli G; Laureti S; Pierangeli F; Rizzello F; Ugolini F; Gionchetti P; Campieri M
Dis Colon Rectum; 2005 Apr; 48(4):768-74. PubMed ID: 15768185
[TBL] [Abstract][Full Text] [Related]
17. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Review and Meta-analysis of Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn's Disease: Progress Made and Future Directions.
Lightner AL; Wang Z; Zubair AC; Dozois EJ
Dis Colon Rectum; 2018 May; 61(5):629-640. PubMed ID: 29578916
[TBL] [Abstract][Full Text] [Related]
19. Review of local injection of anti-TNF for perianal fistulising Crohn's disease.
Adegbola SO; Sahnan K; Tozer PJ; Phillips RK; Faiz OD; Warusavitarne J; Hart A
Int J Colorectal Dis; 2017 Nov; 32(11):1539-1544. PubMed ID: 28900730
[TBL] [Abstract][Full Text] [Related]
20. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas.
Tozer P; Ng SC; Siddiqui MR; Plamondon S; Burling D; Gupta A; Swatton A; Tripoli S; Vaizey CJ; Kamm MA; Phillips R; Hart A
Inflamm Bowel Dis; 2012 Oct; 18(10):1825-34. PubMed ID: 22223472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
